[Back]
Assoz. Prof. Mag. Dr. Verena Pichler
T: +43-1-4277-55624
Winter term 2024
270040 VO Medizinische Radiochemie 1 - Radiopharmazeutische Chemie für die nuklearmedizinische Diagnostik und Therapie
321013 PR Arzneistoffsynthese - B7 - (5 Kurse)
322026 VU Ausgewählte Kapitel aus der pharmazeutisch-chemischen Forschung - M13
323005 VO Preclinical Drug Development - MPS4
323009 PR Lab Rotation I - MPS8
323010 PR Lab Rotation II - MPS8
Summer term 2024
321013 PR Arzneistoffsynthese - B7 - (4 Kurse)
322022 VU Ausgewählte Kapitel aus der pharmazeutisch-chemischen Forschung - M13
323114 VU The path from bench to bedside - a regulatory view - MPS5
950133 VO Allgemeine und angewandte (med.) Biochemie
Winter term 2023
270015 VO Medizinische Radiochemie 1 - Radiopharmazeutische Chemie für die nuklearmedizinische Diagnostik und Therapie
321013 PR Arzneistoffsynthese - B7 - (5 Kurse)
321113 PR Arzneistoffsynthese - B7 - Zusatzkurse - (3 Kurse)
322022 VU Ausgewählte Kapitel aus der pharmazeutisch-chemischen Forschung - M13
323005 VO Preclinical Drug Development - MPS4
323009 PR Lab Rotation I - MPS8
323010 PR Lab Rotation II - MPS8
41 - 60 out of 95
Ozenil M, Aronow J, Piljak D, Vraka C, Holzer W, Spreitzer H et al. Synthesis, Biological, and Computational Evaluation of Antagonistic, Chiral Hydrobenzoin Esters of Arecaidine Targeting mAChR M1. Pharmaceuticals. 2020 Nov 30;13(12):1-12. 437. doi: 10.3390/ph13120437
Ozenil M, Pacher K, Balber T, Vraka C, Roller A, Holzer W et al. Enhanced arecoline derivatives as muscarinic acetylcholine receptor M1 ligands for potential application as PET radiotracers. European Journal of Medicinal Chemistry. 2020 Oct 15;204:112623. doi: 10.1016/j.ejmech.2020.112623
Klebermass EM, Mahmudi M, Miller A, Pichler V, Vraka C, Balber T et al. 2-[F-18]FDG metabolism: The role of alternative metabolic pathways. European Journal of Nuclear Medicine and Molecular Imaging. 2020 Sept;47(Suppl 1):S12-S13. OP-022. doi: 10.1007/s00259-020-04988-4
Mayerhoefer ME, Haug A, Jäger U, Pichler V, Pfaff S, Wester HJ et al. In Human Visualization of Ibrutinib-Induced CLL Compartment Shift. Cancer immunology research. 2020 Aug;8(8):984-989. doi: 10.1158/2326-6066.CIR-19-0880
Baldinger-Melich P, Gryglewski G, Philippe C, Murgaš M, James GM, Vraka C et al. Corrigendum to "The effect of electroconvulsive therapy on cerebral monoamine oxidase a expression in treatment-resistant depression investigated using positron emission tomography" [Brain Stimul 12 (3) (2019) 714-723]. Brain Stimulation. 2020 Jun 26;13(5):1280-1281. doi: 10.1016/j.brs.2020.06.009
Unterholzner J, Gryglewski G, Philippe C, Seiger R, Pichler V, Godbersen GM et al. Topologically Guided Prioritization of Candidate Gene Transcripts Coexpressed with the 5-HT1A Receptor by Combining in Vivo PET and Allen Human Brain Atlas Data. Cerebral Cortex. 2020 May 18;30(6):3771-3780. doi: 10.1093/cercor/bhz341
Hahn A, Breakspear M, Rischka L, Wadsak W, Godbersen GM, Pichler V et al. Reconfiguration of functional brain networks and metabolic cost converge during task performance. eLife. 2020 Apr 21;9:e52443. doi: 10.7554/eLife.52443
Rasul S, Geist BK, Brath H, Baltzer P, Sundar LKS, Pichler V et al. Response evaluation of SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus using 18F-FDG PET/MRI. BMJ open diabetes research & care. 2020 Mar;8(1):e001135. doi: 10.1136/bmjdrc-2019-001135
Beitzke D, Rasul S, Lassen ML, Pichler V, Senn D, Stelzmüller ME et al. Assessment of Myocardial Viability in Ischemic Heart Disease by PET/MRI: Comparison of Left Ventricular Perfusion, Hibernation, and Scar Burden. Academic radiology. 2020 Feb;27(2):188-197. doi: 10.1016/j.acra.2019.03.021
Weidenauer A, Bauer M, Sauerzopf U, Bartova L, Nics L, Pfaff S et al. On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D2/3 receptor agonist radioligand study. Translational Psychiatry. 2020 Jan 8;10(1):2. doi: 10.1038/s41398-019-0681-5
Beitzke D, Wielandner A, Wollenweber T, Vraka C, Pichler V, Uyanik-Uenal K et al. Assessment of sympathetic reinnervation after cardiac transplantation using hybrid cardiac PET/MRI: A pilot study. Journal of magnetic resonance imaging : JMRI. 2019 Oct;50(4):1326-1335. doi: 10.1002/jmri.26722
Silberbauer LR, Gryglewski G, Berroterán-Infante N, Rischka L, Vanicek T, Pichler V et al. Serotonin transporter binding in the human brain after pharmacological challenge measured using PET and PET/MR. Frontiers in molecular neuroscience. 2019 Jul 12;12:172. doi: 10.3389/fnmol.2019.00172
Tournier N, Bauer M, Pichler V, Nics L, Klebermass EM, Bamminger K et al. Impact of P-glycoprotein Function on the Brain Kinetics of the Weak Substrate 11C-Metoclopramide Assessed with PET Imaging in Humans. The Journal of Nuclear Medicine. 2019 Jul 1;60(7):985-991. Epub 2019 Jan 10. doi: 10.2967/jnumed.118.219972
Gryglewski G, Klöbl M, Berroterán-Infante N, Rischka L, Balber T, Vanicek T et al. Modeling the acute pharmacological response to selective serotonin reuptake inhibitors in human brain using simultaneous PET/MR imaging. European Neuropsychopharmacology. 2019 Jun;29(6):711-719. doi: 10.1016/j.euroneuro.2019.04.001
Pfaff S, Philippe C, Nics L, Berroteran-Infante N, Pallitsch K, Rami-Mark C et al. Facilitated troubleshooting in (+)-[C-11]PHNO synthesis by investigation of reagents, byproducts, and intermediates. Journal of Labelled Compounds and Radiopharmaceuticals. 2019 May;62:255-257.
Vraka C, Pichler V, Pfaff S, Balber T, Hacker M, Mitterhauser M et al. Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [11C]SNAP-7941. Journal of Visualized Experiments. 2019 Apr 28;(146):e59557. doi: 10.3791/59557
Nakuz TS, Millinger FP, El-Rabadi K, Weber M, Pichler V, Wadsak W et al. Characterization of Bone Lesions in Myeloma Before and During Anticancer Therapy Using 18F-FDG-PET/CT and 18F-NaF-PET/CT. Anticancer Research. 2019 Apr;39(4):1943-1952. doi: 10.21873/anticanres.13304
Vraka C, Pichler V, Berroterán-Infante N, Wollenweber T, Pillinger A, Hohensinner M et al. Optimization of the Automated Synthesis of [ 11C ]mHED—Administered and Apparent Molar Activities. Pharmaceuticals. 2019 Jan 14;12(1):12. doi: 10.3390/ph12010012
Gryglewski G, Philippe C, James GM, Vraka C, Silberbauer L, Balber T et al. The effect of electroconvulsive therapy on cerebral monoamine oxidase A expression in treatment-resistant depression investigated using positron emission tomography. Brain Stimulation. 2019 Jan 13;12(3):714-723. doi: 10.1016/j.brs.2018.12.976
Pfaff S, Philippe C, Nics L, Berroteran-Infante N, Pallitsch K, Rami-Mark C et al. Toward the Optimization of (+)-[11C]PHNO Synthesis: Time Reduction and Process Validation. Contrast media & molecular imaging. 2019;2019:4292596. doi: 10.1155/2019/4292596
41 - 60 out of 95

Research Club, Accumulation of micro- and nanoplastic in colorectal cancer cells

Verena Pichler (Speaker)

13 Dec 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

How to label micro- and nanoplastic

Verena Pichler (Speaker)

27 Sept 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Lecture: Medicinal Radiochemistry

Verena Pichler (Speaker)

17 May 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

FFG Project Spheriograph, Dynamic 3D cell culture method

Verena Pichler (Speaker)

2 May 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Strategies for 18-Fluorine labelling of exendin-4

Verena Pichler (Speaker)

1 Mar 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Isotopes' Availability

Verena Pichler (Speaker)

22 Oct 2021

Activity: Talks and presentations › Talk or oral contribution › Science to Science

First-in-human brain imaging of the GluN2B-containing N-methyl-D-aspartate receptor with (R)-11C-Me-NB1 PET

Lucas Rischka (Speaker), Chrysoula Vraka (Contributor), Verena Pichler (Contributor), Sazan Rasul (Contributor), Lukas Nics (Contributor), Gregor Gryglewski (Contributor), Patricia A. Handschuh (Contributor), Matej Murgaš (Contributor), G. N. Godbersen (Contributor), Leo Silberbauer (Contributor), M. Unterholzner (Contributor), C. Wotawa (Contributor), A. Haider (Contributor), H. Ahmed (Contributor), Roger Schibli (Contributor), Thomas Mindt (Contributor), Markus Mitterhauser (Contributor), Wolfgang Wadsak (Contributor), A. Hahn (Contributor), Rupert Lanzenberger (Contributor), Markus Hacker (Contributor) & Simon M. Ametamey (Contributor)

20 Oct 2021

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Imaging Probes based on Small Molecules with Emphasis on PET

Verena Pichler (Speaker)

24 Aug 2021

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Quantification of radiotracer accumulation in a dynamic column-based 3D cell culture

Verena Pichler (Speaker)

17 May 2021

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Differences and similarities between symmetrically and unsymmetrically substituted PtIV complexes with N,(N)-(di)alkylethane-1,2-diamine ligands

Verena Pichler (Speaker)

8 Sept 2013

Activity: Talks and presentations › Talk or oral contribution › Other

Department of Pharmaceutical Sciences

Strahlenschutzbeauftragte

Josef-Holaubek-Platz 2 (UZA II)
1090 Wien
Room: 2E306

T: +43-1-4277-55624

verena.pichler@univie.ac.at